Not a good buy right now for an impatient buyer: price action is weak near support and short-term pattern stats skew negative.
Trend is conflicted (bullish long/medium MAs, but bearish MACD momentum), and the stock is still below the key pivot (4.427).
Options positioning is extremely call-heavy (bullish sentiment), but implied volatility is very elevated vs realized, suggesting heightened uncertainty into earnings (2026-02-23).
With no proprietary buy signals (AI Stock Picker/SwingMax) and deteriorating profitability trends (latest quarter), the risk/reward is not attractive right now.
RSI: RSI_6 at 45.6 = neutral, no oversold bounce signal.
Moving averages: SMA_5 > SMA_20 > SMA_200 = constructive broader structure, but current momentum is still fading.
Key levels: Pivot 4.427 (price below pivot is bearish bias). Support S1 4.263 then S2 4.162; Resistance R1 4.592 then R2 4.693.
Near-term bias (pattern stats): 70% chance of downside with estimates of -1.97% (next day), -1.79% (next week), -1.68% (next month) based on similar candlestick patterns.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Put/Call open interest ratio 0.04 (very call-heavy) and put volume = 0 today → bullish/optimistic skew.
Activity: Today’s volume 62 with volume vs 30D avg at 32.12 (spike off a low base); today’s open interest 11,702 and today vs OI avg 113.87 (elevated engagement).
Volatility: 30D IV 86.29 vs historical vol 29.38 → options are pricing large moves / elevated uncertainty, consistent with upcoming earnings.
Interpretation: Sentiment is bullish, but the high IV means the market expects turbulence; this does not confirm a clean “buy now” setup in the underlying.
Technical Summary
Sell
4
Buy
6
Positive Catalysts
on 2026-02-23 after hours could act as a catalyst if margins/profitability rebound vs recent weakness.
Neutral/Negative Catalysts
and is leaning on nearby support (S1 4.263), increasing risk of a breakdown toward S2 4.
No supportive news flow in the last week (no fresh positive catalyst).
Net income: 198.1M, -18.45% YoY (profitability worsening).
EPS: 0.10, -16.67% YoY (earnings power declined).
Gross margin: 11.91, -19.69% YoY (margin compression is the key negative trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent analyst trend is mixed and slightly negative at the margin:
2026-01-22: BTG Pactual downgraded to Neutral from Buy, PT R$27 (more cautious stance).
2025-12-15: UBS kept Buy and raised PT to $4.60 from $4 (constructive view).
Wall Street pros: revenue growth, potential cyclicality upside, one major firm maintains Buy with higher PT.
Wall Street cons: a fresh downgrade signals softer confidence; profitability/margins have been trending down, which can limit upside even if revenue grows.
Influential/political trading: No recent congress trading data available; no politician activity provided.
Wall Street analysts forecast GGB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GGB is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast GGB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GGB is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 4.180
Low
0
Averages
0
High
0
0
Current: 4.180
Low
0
Averages
0
High
0
BTG Pactual
Buy -> Neutral
downgrade
R$27
AI Analysis
2026-01-22
Reason
BTG Pactual
Price Target
R$27
AI Analysis
2026-01-22
downgrade
Buy -> Neutral
Reason
BTG Pactual downgraded Gerdau to Neutral from Buy with a R$27 price target.
UBS
Buy
maintain
$4
2025-12-15
Reason
UBS
Price Target
$4
2025-12-15
maintain
Buy
Reason
UBS raised the firm's price target on Gerdau to $4.60 from $4 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GGB